Mengapa Korea Memimpin Dunia dalam Kedokteran Regeneratif
Government R&D investment, the world's first approved sel punca therapeutics, and the fusion of K-Kecantikan with regenerative medicine — we analyze how Korea became a global leader in regenerative medicine.
Why Korea Leads the World in Regenerative Medicine
As of 2026, Korea ranks 3rd globally in regenerative medicine publications and 1st in approved sel punca therapeutics. Behind these achievements are aggressive government R&D investment, world-class medical infrastructure, and a rapid klinikal application system.
Government-Led Bio R&D Investment
The Korea government has invested over ₩500 billion annually in regenerative medicine since 2020, expanding to ₩800 billion in 2026 — the second largest in Asia after Japan.
World's First Approved Sel Punca Therapeutics
Korea was the first country to officially approve sel punca therapeutics. To date, five sel punca therapies have been approved and are actively used in klinikal practice.
The Fusion of K-Kecantikan and Regenerative Medicine
Korea's unique strength lies in innovative perawatans that blur the line between cosmetics and regenerative medicine — sel punca growth factor kulitcare, exosome-based anti-penuaan, and combined regenerative laser-sel punca therapies.
Why Get Treated in Korea
1) World-leading technology 2) 1/3 to 1/5 the cost of the US and Japan 3) State-of-the-art facilities and equipment 4) Multilingual medical coordinators. Experience the future of regenerative medicine in Korea.
이 기사에 소개된 병원이 궁금하신가요?
Sains K-Beauty — Sel Punca & Kedokteran Regeneratif 전체 보기
